Anixa Biosciences

635 posts

Anixa Biosciences

@AnixaBio

Anixa Biosciences (NASDAQ: $ANIX) is focused on the treatment and prevention of cancer.

Katılım Aralık 2015

145 Takip Edilen588 Takipçiler

Anixa Biosciences@AnixaBio·4d

📰 New industry coverage from Outsourced Pharma The article highlights why Anixa Biosciences' investigational breast cancer vaccine represents more than another clinical program—it reflects a bold vision for the future of cancer prevention and immunotherapy. Read the article: outsourcedpharma.com/doc/a-vaccine-… #AnixaBiosciences #Biotech #Immunotherapy #BreastCancer #CancerResearch #ANIX

English

633

Anixa Biosciences@AnixaBio·4 May

Patient who received breast cancer vaccine as part of clinical trial speaks about experience wptv.com/news/treasure-…

English

253

Anixa Biosciences@AnixaBio·4 May

🎥 #ICYMI: Anixa Biosciences CEO Dr. Amit Kumar appeared on the RedChip Small Stocks, Big Money show on Bloomberg TV. Discussion highlights: ✔️ Breast cancer vaccine Phase 1 data (immune responses in 74% of participants) ✔️ Progress toward Phase 2 ✔️ Ovarian cancer CAR-T program updates ▶️ Watch the interview: youtube.com/watch?v=92m_0L… #AnixaBiosciences #Biotech #Immunotherapy #CancerResearch #ANIX

YouTube

English

637

Anixa Biosciences@AnixaBio·22 Nis

We appreciate the continued coverage from Water Tower Research. At Anixa Biosciences, we are advancing differentiated immunotherapy programs, including our therapeutic and preventative breast cancer vaccine and lira-cel, our CAR-T therapy for ovarian cancer. #AnixaBiosciences #Biotech #Immunotherapy #Oncology #CancerResearch #ANIX

Water Tower Research LLC@WTR_Research

Dr. Amit Kumar, CEO of @AnixaBio joined us for a fireside chat at the WTR Insights Conference, sharing insights into the company’s strategy, pipeline progress, and long-term growth opportunities. The discussion provides a deeper look at key themes shaping Anixa’s outlook, with additional opportunities to connect with management available through the conference portal. Make sure to check out the on-demand replay at the link here: event.webcasts.com/starthere.jsp?… $ANIX #AnixaBiosciences #Biotech #Immunotherapy #CART #CancerResearch #BreastCancer #OvarianCancer #CancerVaccine #Oncology #ClinicalTrials #BiotechStocks #HealthcareInnovation #LifeSciences #InvestorInsights #WaterTowerResearch

English

492

Anixa Biosciences@AnixaBio·15 Nis

We’re proud to collaborate with Moffitt Cancer Center on advancing innovative immunotherapy approaches. Our joint work on CAR-T technology for ovarian cancer reflects a shared commitment to developing differentiated solutions for patients with significant unmet needs. Appreciate the continued leadership and partnership. #AnixaBiosciences #MoffittCancerCenter #Biotech #Immunotherapy #CancerResearch

Moffitt Cancer Center@MoffittNews

x.com/i/article/2044…

English

210

Anixa Biosciences@AnixaBio·10 Nis

We’re pleased to share that Anixa Biosciences will be presenting at the Water Tower Research Insights Conference. 🎤 Dr. Amit Kumar, Chairman & CEO 📅 April 14, 2026 ⏰ 12:30 PM ET Join us as we discuss our clinical programs, including our breast cancer vaccine and CAR-T platform for ovarian cancer. 🔗 Register here: event.webcasts.com/starthere.jsp?… #AnixaBiosciences #Biotech #Immunotherapy #CancerResearch #ANIX

English

128

Anixa Biosciences@AnixaBio·8 Nis

We believe Anixa Biosciences is well positioned at the forefront of next-generation oncology innovation. With our breast cancer vaccine program (in collaboration with Cleveland Clinic) and our CAR-T platform targeting solid tumors, we are advancing differentiated immunotherapy approaches with significant potential. Momentum in this space continues to build. #AnixaBiosciences #Biotech #Immunotherapy #CancerResearch #ANIX

Business-News-Today.com@BNTBriefing

Why Anixa Biosciences’ Phase 2 breast cancer vaccine push matters more than the manufacturing deal itself pharmadevicenews.com/why-anixa-bios… Anixa Biosciences is advancing its breast cancer vaccine toward Phase 2 after positive Phase 1 data. Read what this means for oncology watchers. #AnixaBiosciences #BreastCancerVaccine #TripleNegativeBreastCancer #CancerImmunotherapy #Oncology #Biotech #ClinicalTrials #Cytovance #ClevelandClinic #Phase2Trial @AnixaBio

English

206

Anixa Biosciences@AnixaBio·1 Nis

Our CEO, Dr. Amit Kumar, joined Smart Money Circle with Adam Sarhan to discuss Anixa’s innovative approach to cancer treatment and prevention. Watch the full interview: youtu.be/96uSUv6CzuY Thank you @adamsarhan for the conversation. #Biotech #CancerResearch #Immunotherapy #Oncology #Innovation #Healthcare

YouTube

English

432

Anixa Biosciences retweetledi

Water Tower Research LLC@WTR_Research·13 Mar

Check out our latest Healthcare Happenings as we welcome back Dr. Amit Kumar, Chairman and CEO of Anixa Biosciences, Inc. (NASDAQ: $ANIX) who explains why 2026 is shaping up to be a pivotal year for the company. Hosted by WTR's Tim Gerdeman & Robert Sassoon. Check out the full episode below! Podcast Platforms: pod.link/1795488592 Website: watertowerresearch.com/media-detail/3… #HealthcareInvesting #Biotech #BiotechStocks $ANIX #CancerResearch #Immunotherapy #BiotechInnovation #HealthcareStocks #LifeSciences #ClinicalDevelopment #PrecisionMedicine #SmallCapBiotech #InvestorInsights #HealthcareInnovation @AnixaBio

English

342

Anixa Biosciences@AnixaBio·12 Mar

🎙️ New Podcast: Water Tower Research In this episode of WTR Healthcare Happenings, Anixa Biosciences CEO Dr. Amit Kumar discusses why 2026 may be a pivotal year for Anixa. 🎧 Listen here: watertowerresearch.com/media-detail/3… The discussion also explores Anixa’s clinical-stage programs, including its ovarian cancer immunotherapy and breast cancer vaccine initiatives. #AnixaBiosciences #Biotech #CancerResearch #Immunotherapy #ANIX

English

130

Anixa Biosciences@AnixaBio·6 Mar

🎙️ New podcast: Can we prevent breast cancer? In this episode, Anixa Biosciences CEO Dr. Amit Kumar discusses the investigational breast cancer vaccine being developed in collaboration with Cleveland Clinic and the clinical research exploring how immunotherapy may help prevent or treat the disease. ▶️ Watch on YouTube: youtube.com/watch?v=_Ijeme… 🎧 Listen on: Spotify: open.spotify.com/episode/0JxKKR… Apple Podcasts: podcasts.apple.com/us/podcast/can… 📺 Media coverage: foxcarolina.com/video/2026/03/… #AnixaBiosciences #Biotech #Immunotherapy #CancerResearch #BreastCancer

YouTube

English

363

Anixa Biosciences@AnixaBio·4 Mar

An investigational breast cancer vaccine being developed by Anixa Biosciences in collaboration with Cleveland Clinic is featured in new NBC Chicago coverage. The program is exploring an immunotherapy approach designed to train the immune system to target a protein associated with breast cancer. 🎥 Watch the story: nbcchicago.com/video/local/va… #AnixaBiosciences #Biotech #CancerResearch #Immunotherapy #ClinicalTrials

English

138

Anixa Biosciences@AnixaBio·27 Şub

Advancing innovation in the fight against breast cancer 💙 A patient in a clinical trial of our investigational breast cancer vaccine shares her experience—highlighting the potential of this novel immunotherapy approach. Read more via @foxcarolinanews: foxcarolina.com/2026/02/26/bre… #BreastCancer #CancerVaccine #Immunotherapy #ClinicalTrials #Biotech #Oncology

English

107

Anixa Biosciences@AnixaBio·10 Şub

Encouraging observations from our ovarian cancer CAR-T clinical trial. Multiple patients are living significantly longer than expected and no dose-limiting toxicities have been observed to date. These results support expanded dosing and continued clinical evaluation. 🔗Read the full press release: ir.anixa.com/press-releases… $ANIX #AnixaBiosciences #CARTTherapy #CancerResearch #ClinicalTrials

English

186

Anixa Biosciences@AnixaBio·9 Şub

Looking forward to our fireside chat with Robert Sassoon of @WTR_Research at 11:00am ET on Tuesday, February 10. Register to attend here: event.webcasts.com/starthere.jsp?…

Water Tower Research LLC@WTR_Research

Please join Robert Sassoon for a fireside chat Anixa Biosciences, Inc. with Chairman & CEO Dr. Amit Kumar, PhD on Tuesday, February 10, 2026, at 11:00 am ET. Register below! event.webcasts.com/starthere.jsp?… $ANIX #AnixaBiosciences #FiresideChat #Healthcare #SmallCap #Stocks #Investing @AnixaBio

English

200

Anixa Biosciences@AnixaBio·23 Oca

We're listening to iHeart ♫ @iHeartRadio iheart.com/podcast/176-sa…

English

224

Anixa Biosciences@AnixaBio·29 Ara

We’re happy to share additional coverage highlighting that the breast cancer vaccine trial, developed with partners including Cleveland Clinic, is advancing into Phase 2 testing after an immune response in over 70% of participants and a favorable safety profile. Phase 2 will include more participants and control comparisons to further evaluate safety and efficacy. 🔗Full article: ideastream.org/health/2025-12… $ANIX #AnixaBiosciences #BreastCancerVaccine #Immunotherapy #ClinicalTrials #Biotech

Ideastream News@Ideastream

Cleveland Clinic advances promising breast cancer vaccine to second phase trial ideastream.org/health/2025-12…

English

342

Anixa Biosciences@AnixaBio·24 Ara

We’re encouraged by worldwide coverage, including by @timesofindia, of the Phase 1 clinical trial results showing our breast cancer vaccine was safe, well-tolerated, and triggered a strong immune response, a hopeful step in the fight against this aggressive disease. 🔗Read the full article: timesofindia.indiatimes.com/life-style/hea… $ANIX #AnixaBiosciences #BreastCancer #CancerResearch #Immunotherapy #Biotech

English

198

Anixa Biosciences@AnixaBio·23 Ara

We’re pleased by news coverage from @NBCNews on the promising Phase 1 clinical trial results for our breast cancer vaccine that generated strong immune responses in Phase 1 — a hopeful step toward prevention and less recurrence for this aggressive cancer subtype. 🔗Read more: nbcnews.com/health/cancer/… $ANIX #AnixaBiosciences #BreastCancer #Immunotherapy #CancerResearch #Biotech

English

166

Anixa Biosciences@AnixaBio·22 Ara

📢 We’re encouraged by the promising Phase 1 results from our breast cancer vaccine trial developed in collaboration with Cleveland Clinic — showing the vaccine is safe and triggered an immune response in over 70% of participants. 🔗 Read more: wkyc.com/article/news/h… $ANIX #AnixaBiosciences #BreastCancerVaccine #Immunotherapy #ClinicalTrials #Biotech

English

405

Keşfet

@adamsarhan @foxcarolinanews @WTR_Research @iHeartRadio @timesofindia @NBCNews @elonmusk @BarackObama